We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to read.

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...

Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

Clesrovimab scored on several endpoints, showing an ability to protect infants against the virus in their first RSV season.

We recently published a list of 10 Most Promising Low-Cost Stocks According to Hedge Funds. In this article, we are going to ...

On Oct. 1 and 2, the American Chemical Society held its 21st annual Pharma Leaders Conference, hosted this year at the Merck & Co. campus in Rahway, New Jersey. Leaders in medicinal chemistry from ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...